Target intelligence / Profile preview

Tissue injury and inflammation microenvironment

Molecular classification
Other
01

Overview

The tissue injury and inflammation microenvironment is a complex, multi-cellular milieu consisting of immune cells, stromal cells, and a diverse array of signaling molecules such as cytokines and chemokines (Medzhitov, Nature, 2008). This environment is initiated by damage-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns (PAMPs) that trigger an innate immune response to contain injury and initiate repair (Chen & Nuñez, Nature Reviews Immunology, 2010). While essential for host defense and wound healing, a persistent or dysregulated inflammatory microenvironment is a key driver of chronic diseases, including fibrosis, autoimmune disorders, and the progression of various cancers (Hanahan & Weinberg, Cell, 2011). Therapeutic intervention typically involves targeting specific nodes within this network, such as the TNF-alpha or IL-6 pathways, rather than the environment as a whole (Neurath, Nature Reviews Immunology, 2014). Monitoring this microenvironment often relies on systemic biomarkers like C-reactive protein or local cytokine profiling to assess the state of inflammation and response to treatment (Gabay & Kushner, New England Journal of Medicine, 1999). Because this is a physiological state rather than a single molecular target, drug development focuses on modulating the balance of pro- and anti-inflammatory factors to restore tissue homeostasis.

Other names
Inflammatory microenvironmentPro-inflammatory milieuWound healing nicheTissue injury niche
02

Mechanism of action

Modulation of the inflammatory milieu through the inhibition of specific cytokines, chemokines, or immune cell signaling pathways to resolve inflammation and promote tissue repair.

03

Biological functions

Immune responseWound healingSignal transductionCell proliferationApoptosis
04

Disease associations

InflammationCancerFibrosisAutoimmune diseaseInfection
05

Safety considerations

Increased risk of infectionImpaired wound healingSystemic immunosuppressionPotential for paradoxical inflammatory reactions
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Tissue injury and inflammation microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue injury and inflammation microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call